Mesenchymal-like BCSCs with CD44+/CD24− characteristics are primarily quiescent and placed at the tumor-invasive front, while epithelial-like BCSCs express ALDH1, are proliferative, and are more centrally located. The gene discussed is CD44; the disease is neoplasm.